Ocwen Financial Corp. (NYSE:OCN) represented a move of 3.64 percent or $-0.2 per share and closed its previous day trading session at $3.7. 1.34 Million Shares were traded in the last trading session with an Average Volume of 1.53 Million Shares. The stock currently has a Market Capitalization of 491.88 Million.
Ocwen Financial Corporation is a financial services holding company engaged in asset acquisition and resolution, residential finance, commercial finance, investment management and hotel operations. The Company primarily specializes in the aquisition and resolution of non-performing or underperforming loans.
The stock traded between $2.12 and $5.95 over 1-Year time period showing its price to sales ratio of 0.4. Ocwen Financial Corp. (NYSE:OCN) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $16.37 and 200-Day Simple Moving Average of $21.67. Its Price to Free Cash Flow is 0.94 and Price to Book of 0.81.
Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Ocwen Financial Corp. (NYSE:OCN) reported its Actual EPS of $-0.05/share. The analysts offering Earnings Estimates for the company were believing that Ocwen Financial Corp. could bring EPS of $-0.1/share. The difference between Actual EPS and Estimated EPS was 0.05 Percent. Thus showing an Earnings Surprise of 50 Percent.
Dynavax Technologies Corporation (NASDAQ:DVAX)
In the last trading session, Dynavax Technologies Corporation (NASDAQ:DVAX) added its value by -2.33% closing at the price of $16.8. The stock currently has market capitalization of 1.04 Billion, with average volume of 1.41 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Dynavax Technologies Corporation (NASDAQ:DVAX) is showing beta of 0.86. This particular value of beta suggests that Dynavax Technologies Corporation (NASDAQ:DVAX) has historically moved 86% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Dynavax Technologies Corporation (NASDAQ:DVAX) is at $-1.96.
The stock currently has RSI of 46.97. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax’s clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Dynavax Technologies Corporation (NASDAQ:DVAX) topped its 52-week high price of $24.45 on 10/05/17 and 52-Week Low Price of $ 3.90 on 02/23/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.44% and monthly volatility of 6.24% respectively.